Neogen (NEOG) Competitors $12.13 +0.28 (+2.36%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NEOG vs. MMSI, HAE, XRAY, ICUI, QDEL, STAA, CERS, OSUR, ANIK, and UTMDShould you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Merit Medical Systems (MMSI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), ICU Medical (ICUI), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), and Utah Medical Products (UTMD). These companies are all part of the "health care supplies" industry. Neogen vs. Merit Medical Systems Haemonetics DENTSPLY SIRONA ICU Medical QuidelOrtho STAAR Surgical Cerus OraSure Technologies Anika Therapeutics Utah Medical Products Neogen (NASDAQ:NEOG) and Merit Medical Systems (NASDAQ:MMSI) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership, risk and community ranking. Does the MarketBeat Community prefer NEOG or MMSI? Merit Medical Systems received 104 more outperform votes than Neogen when rated by MarketBeat users. Likewise, 69.33% of users gave Merit Medical Systems an outperform vote while only 56.60% of users gave Neogen an outperform vote. CompanyUnderperformOutperformNeogenOutperform Votes33056.60% Underperform Votes25343.40% Merit Medical SystemsOutperform Votes43469.33% Underperform Votes19230.67% Do analysts recommend NEOG or MMSI? Neogen presently has a consensus target price of $17.50, indicating a potential upside of 44.27%. Merit Medical Systems has a consensus target price of $105.09, indicating a potential upside of 6.15%. Given Neogen's higher possible upside, equities analysts plainly believe Neogen is more favorable than Merit Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Merit Medical Systems 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do insiders and institutionals have more ownership in NEOG or MMSI? 96.7% of Neogen shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 1.1% of Neogen shares are owned by insiders. Comparatively, 3.7% of Merit Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media favor NEOG or MMSI? In the previous week, Merit Medical Systems had 15 more articles in the media than Neogen. MarketBeat recorded 18 mentions for Merit Medical Systems and 3 mentions for Neogen. Merit Medical Systems' average media sentiment score of 1.00 beat Neogen's score of 0.71 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 9 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Is NEOG or MMSI more profitable? Merit Medical Systems has a net margin of 9.05% compared to Neogen's net margin of -2.58%. Merit Medical Systems' return on equity of 15.61% beat Neogen's return on equity.Company Net Margins Return on Equity Return on Assets Neogen-2.58% 2.80% 1.93% Merit Medical Systems 9.05%15.61%8.38% Which has more risk & volatility, NEOG or MMSI? Neogen has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Which has stronger valuation & earnings, NEOG or MMSI? Merit Medical Systems has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeogen$912.20M2.88-$9.42M-$0.11-110.27Merit Medical Systems$1.33B4.35$94.41M$2.0448.53 SummaryMerit Medical Systems beats Neogen on 17 of the 19 factors compared between the two stocks. Ad Crypto 101 MediaDeFi Coin on Verge of Breakout![FREE BOOK] Can You Make a Fortune in Crypto with $50? Get started now before the market takes off! Click here to request your free copy NOW! Get Neogen News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEOG vs. The Competition Export to ExcelMetricNeogenDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.57B$2.71B$5.20B$9.31BDividend YieldN/A0.74%4.80%4.06%P/E Ratio-110.276.29128.1117.53Price / Sales2.8872.271,260.62139.54Price / Cash12.3915.1641.3637.95Price / Book0.843.344.894.92Net Income-$9.42M$31.95M$119.92M$225.78M7 Day Performance-4.49%-3.95%16.64%-1.56%1 Month Performance-20.20%12.11%16.35%6.68%1 Year Performance-38.30%-19.68%35.47%22.48% Neogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEOGNeogen3.5759 of 5 stars$12.13+2.4%$17.50+44.3%-37.5%$2.57B$912.20M-110.272,640MMSIMerit Medical Systems4.4434 of 5 stars$102.90+0.1%$105.09+2.1%+38.3%$6.00B$1.33B50.476,950HAEHaemonetics4.6739 of 5 stars$82.28+1.3%$108.78+32.2%-8.0%$4.13B$1.36B33.693,657Positive NewsXRAYDENTSPLY SIRONA4.8947 of 5 stars$20.03+1.6%$28.40+41.8%-44.2%$3.98B$3.90B-9.5315,000Dividend AnnouncementAnalyst ForecastICUIICU Medical4.6049 of 5 stars$161.28-0.2%$199.67+23.8%+58.1%$3.95B$2.34B-35.3714,000QDELQuidelOrtho4.2272 of 5 stars$43.00+4.0%$53.43+24.3%-39.4%$2.89B$3.00B-1.577,100Gap UpSTAASTAAR Surgical4.6411 of 5 stars$24.37-2.0%$42.83+75.8%-23.9%$1.20B$322.42M56.501,115CERSCerus2.9613 of 5 stars$1.82+6.1%$3.63+99.7%-21.0%$337.07M$176.23M-15.55625News CoveragePositive NewsOSUROraSure Technologies4.5093 of 5 stars$4.01+2.6%$5.50+37.2%-49.4%$299.12M$224.26M27.60638Positive NewsANIKAnika Therapeutics4.1977 of 5 stars$17.12-0.2%$24.50+43.1%-25.5%$250.74M$164.17M-2.58357Positive NewsUTMDUtah Medical Products2.9482 of 5 stars$63.05+0.7%N/A-23.3%$213.74M$50.22M14.73180Short Interest ↑ Related Companies and Tools Related Companies MMSI Competitors HAE Competitors XRAY Competitors ICUI Competitors QDEL Competitors STAA Competitors CERS Competitors OSUR Competitors ANIK Competitors UTMD Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NEOG) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neogen Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
